Institute for Immunity Transplantation and Infection–

Edgar Engleman

Back to Profile

Publication Details

  • An open study of dehydroepiandrosterone in systemic lupus erythematosus.

    van Vollenhoven RF, Engleman EG, McGuire JL. Arthritis Rheum. 1994; 37 (9): 1305-10

    To determine if dehydroepiandrosterone (DHEA) has clinical benefits in patients with systemic lupus erythematosus (SLE).

    PubMedID: 7945493

Stanford Medicine Resources:

Footer Links: